PubMed:7524825
Annnotations
Glycan-Motif
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 19-22 | https://glytoucan.org/Structures/Glycans/G01187XC | denotes | LeX |
| T2 | 148-152 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | SLeX |
| T3 | 154-160 | https://glytoucan.org/Structures/Glycans/G81533KY | denotes | Neu5Ac |
| T4 | 212-218 | https://glytoucan.org/Structures/Glycans/G81533KY | denotes | Neu5Ac |
| T5 | 319-323 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | SLeX |
| T6 | 440-444 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | SLeX |
| T7 | 460-464 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | SLeX |
| T8 | 619-623 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | SLeX |
| T9 | 836-840 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | SLeX |
| T10 | 916-920 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | SLeX |
| T11 | 1193-1197 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | SLeX |
| T12 | 1276-1280 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | SLeX |
| T13 | 1389-1393 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | SLeX |
| T14 | 1636-1640 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | SLeX |
GlyCosmos6-Glycan-Motif-Image
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 19-22 | Glycan_Motif | denotes | LeX | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G01187XC |
| T2 | 148-152 | Glycan_Motif | denotes | SLeX | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO |
| T3 | 154-160 | Glycan_Motif | denotes | Neu5Ac | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81533KY |
| T4 | 212-218 | Glycan_Motif | denotes | Neu5Ac | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81533KY |
| T5 | 319-323 | Glycan_Motif | denotes | SLeX | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO |
| T6 | 440-444 | Glycan_Motif | denotes | SLeX | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO |
| T7 | 460-464 | Glycan_Motif | denotes | SLeX | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO |
| T8 | 619-623 | Glycan_Motif | denotes | SLeX | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO |
| T9 | 836-840 | Glycan_Motif | denotes | SLeX | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO |
| T10 | 916-920 | Glycan_Motif | denotes | SLeX | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO |
| T11 | 1193-1197 | Glycan_Motif | denotes | SLeX | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO |
| T12 | 1276-1280 | Glycan_Motif | denotes | SLeX | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO |
| T13 | 1389-1393 | Glycan_Motif | denotes | SLeX | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO |
| T14 | 1636-1640 | Glycan_Motif | denotes | SLeX | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00054MO |
GlyCosmos6-Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 19-22 | https://glytoucan.org/Structures/Glycans/G01187XC | denotes | LeX |
| T2 | 148-152 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | SLeX |
| T3 | 154-160 | https://glytoucan.org/Structures/Glycans/G81533KY | denotes | Neu5Ac |
| T4 | 212-218 | https://glytoucan.org/Structures/Glycans/G81533KY | denotes | Neu5Ac |
| T5 | 319-323 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | SLeX |
| T6 | 440-444 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | SLeX |
| T7 | 460-464 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | SLeX |
| T8 | 619-623 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | SLeX |
| T9 | 836-840 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | SLeX |
| T10 | 916-920 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | SLeX |
| T11 | 1193-1197 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | SLeX |
| T12 | 1276-1280 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | SLeX |
| T13 | 1389-1393 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | SLeX |
| T14 | 1636-1640 | https://glytoucan.org/Structures/Glycans/G00054MO | denotes | SLeX |
Glycosmos6-MAT
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 1026-1030 | http://purl.obolibrary.org/obo/MAT_0000037 | denotes | vein |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-129 | Sentence | denotes | Multivalent sialyl-LeX: potent inhibitors of E-selectin-mediated cell adhesion; reagent for staining activated endothelial cells. |
| TextSentencer_T2 | 130-434 | Sentence | denotes | Free, monovalent, SLeX (Neu5Ac alpha 2-3Gal beta 1-4(Fuc alpha 1-3)-GlcNAc), SLn (Neu5Ac alpha 2-3Gal beta 1-4GlcNAc) and corresponding BSA-conjugated forms--displaying different ratios of SLeX and SLn to protein--were tested for their ability to inhibit binding of HL-60 cells to immobilized E-selectin. |
| TextSentencer_T3 | 435-519 | Sentence | denotes | Free SLeX and conjugated SLeX-BSA inhibited cell binding in a dose-dependent manner. |
| TextSentencer_T4 | 520-560 | Sentence | denotes | SLn and SLn-BSA did not inhibit binding. |
| TextSentencer_T5 | 561-841 | Sentence | denotes | SLeX16BSA (16 mol tetrasaccharide/mol BSA) and monovalent SLeX inhibited cell binding with measured inhibitory concentrations (IC50S) of 1 microM and 1 mM, respectively, demonstrating a three-order-of-magnitude enhancement of inhibitory activity with the multivalent form of SLeX. |
| TextSentencer_T6 | 842-929 | Sentence | denotes | A SLex7BSA conjugate was 10-fold less potent than those with 11 or 16 mol SLeX/mol BSA. |
| TextSentencer_T7 | 930-1275 | Sentence | denotes | An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM. |
| TextSentencer_T8 | 1276-1375 | Sentence | denotes | SLeX-BSA was found to be an excellent reagent for staining endothelial cells expressing E-selectin. |
| TextSentencer_T9 | 1376-1575 | Sentence | denotes | Biotinylated SLeX-BSA in conjunction with Texas red avidin-stained lipopolysaccharide (LPS)-activated HUVECs, and co-incubation of activated cells with anti-E-selectin, specifically blocked staining. |
| TextSentencer_T10 | 1576-1761 | Sentence | denotes | The distribution of E-selectin, as determined by binding of SLeX-BSA, was virtually identical with that obtained by binding of anti-E-selectin antibody.(ABSTRACT TRUNCATED AT 250 WORDS) |
| T1 | 0-129 | Sentence | denotes | Multivalent sialyl-LeX: potent inhibitors of E-selectin-mediated cell adhesion; reagent for staining activated endothelial cells. |
| T2 | 130-434 | Sentence | denotes | Free, monovalent, SLeX (Neu5Ac alpha 2-3Gal beta 1-4(Fuc alpha 1-3)-GlcNAc), SLn (Neu5Ac alpha 2-3Gal beta 1-4GlcNAc) and corresponding BSA-conjugated forms--displaying different ratios of SLeX and SLn to protein--were tested for their ability to inhibit binding of HL-60 cells to immobilized E-selectin. |
| T3 | 435-519 | Sentence | denotes | Free SLeX and conjugated SLeX-BSA inhibited cell binding in a dose-dependent manner. |
| T4 | 520-560 | Sentence | denotes | SLn and SLn-BSA did not inhibit binding. |
| T5 | 561-841 | Sentence | denotes | SLeX16BSA (16 mol tetrasaccharide/mol BSA) and monovalent SLeX inhibited cell binding with measured inhibitory concentrations (IC50S) of 1 microM and 1 mM, respectively, demonstrating a three-order-of-magnitude enhancement of inhibitory activity with the multivalent form of SLeX. |
| T6 | 842-929 | Sentence | denotes | A SLex7BSA conjugate was 10-fold less potent than those with 11 or 16 mol SLeX/mol BSA. |
| T7 | 930-1275 | Sentence | denotes | An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM. |
| T8 | 1276-1375 | Sentence | denotes | SLeX-BSA was found to be an excellent reagent for staining endothelial cells expressing E-selectin. |
| T9 | 1376-1575 | Sentence | denotes | Biotinylated SLeX-BSA in conjunction with Texas red avidin-stained lipopolysaccharide (LPS)-activated HUVECs, and co-incubation of activated cells with anti-E-selectin, specifically blocked staining. |
| T10 | 1576-1761 | Sentence | denotes | The distribution of E-selectin, as determined by binding of SLeX-BSA, was virtually identical with that obtained by binding of anti-E-selectin antibody.(ABSTRACT TRUNCATED AT 250 WORDS) |
| T1 | 0-129 | Sentence | denotes | Multivalent sialyl-LeX: potent inhibitors of E-selectin-mediated cell adhesion; reagent for staining activated endothelial cells. |
| T2 | 130-434 | Sentence | denotes | Free, monovalent, SLeX (Neu5Ac alpha 2-3Gal beta 1-4(Fuc alpha 1-3)-GlcNAc), SLn (Neu5Ac alpha 2-3Gal beta 1-4GlcNAc) and corresponding BSA-conjugated forms--displaying different ratios of SLeX and SLn to protein--were tested for their ability to inhibit binding of HL-60 cells to immobilized E-selectin. |
| T3 | 435-519 | Sentence | denotes | Free SLeX and conjugated SLeX-BSA inhibited cell binding in a dose-dependent manner. |
| T4 | 520-560 | Sentence | denotes | SLn and SLn-BSA did not inhibit binding. |
| T5 | 561-841 | Sentence | denotes | SLeX16BSA (16 mol tetrasaccharide/mol BSA) and monovalent SLeX inhibited cell binding with measured inhibitory concentrations (IC50S) of 1 microM and 1 mM, respectively, demonstrating a three-order-of-magnitude enhancement of inhibitory activity with the multivalent form of SLeX. |
| T6 | 842-929 | Sentence | denotes | A SLex7BSA conjugate was 10-fold less potent than those with 11 or 16 mol SLeX/mol BSA. |
| T7 | 930-1275 | Sentence | denotes | An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM. |
| T8 | 1276-1375 | Sentence | denotes | SLeX-BSA was found to be an excellent reagent for staining endothelial cells expressing E-selectin. |
| T9 | 1376-1575 | Sentence | denotes | Biotinylated SLeX-BSA in conjunction with Texas red avidin-stained lipopolysaccharide (LPS)-activated HUVECs, and co-incubation of activated cells with anti-E-selectin, specifically blocked staining. |
| T10 | 1576-1761 | Sentence | denotes | The distribution of E-selectin, as determined by binding of SLeX-BSA, was virtually identical with that obtained by binding of anti-E-selectin antibody.(ABSTRACT TRUNCATED AT 250 WORDS) |
ICD10
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 1401-1412 | http://purl.bioontology.org/ontology/ICD10/H10 | denotes | conjunction |
| T2 | 1401-1412 | http://purl.bioontology.org/ontology/ICD10/H10.9 | denotes | conjunction |
GlycoBiology-FMA
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| _T1 | 45-55 | FMAID:167268 | denotes | E-selectin |
| _T2 | 45-55 | FMAID:167267 | denotes | E-selectin |
| _T3 | 45-55 | FMAID:62932 | denotes | E-selectin |
| _T4 | 45-55 | FMAID:62933 | denotes | E-selectin |
| _T5 | 45-55 | FMAID:167265 | denotes | E-selectin |
| _T6 | 45-55 | FMAID:62931 | denotes | E-selectin |
| _T7 | 47-55 | FMAID:165243 | denotes | selectin |
| _T8 | 47-55 | FMAID:61795 | denotes | selectin |
| _T9 | 111-122 | FMAID:63916 | denotes | endothelial |
| _T10 | 111-122 | FMAID:162384 | denotes | endothelial |
| _T11 | 111-128 | FMAID:164926 | denotes | endothelial cells |
| _T12 | 111-128 | FMAID:169653 | denotes | endothelial cells |
| _T13 | 111-128 | FMAID:66772 | denotes | endothelial cells |
| _T14 | 111-128 | FMAID:69075 | denotes | endothelial cells |
| _T15 | 123-128 | FMAID:68646 | denotes | cells |
| _T16 | 123-128 | FMAID:169002 | denotes | cells |
| _T17 | 335-342 | FMAID:67257 | denotes | protein |
| _T18 | 335-342 | FMAID:165447 | denotes | protein |
| _T19 | 349-355 | FMAID:178661 | denotes | tested |
| _T20 | 402-407 | FMAID:169002 | denotes | cells |
| _T21 | 402-407 | FMAID:68646 | denotes | cells |
| _T22 | 423-433 | FMAID:62932 | denotes | E-selectin |
| _T23 | 423-433 | FMAID:62933 | denotes | E-selectin |
| _T24 | 423-433 | FMAID:62931 | denotes | E-selectin |
| _T25 | 423-433 | FMAID:167265 | denotes | E-selectin |
| _T26 | 423-433 | FMAID:167268 | denotes | E-selectin |
| _T27 | 423-433 | FMAID:167267 | denotes | E-selectin |
| _T28 | 425-433 | FMAID:165243 | denotes | selectin |
| _T29 | 425-433 | FMAID:61795 | denotes | selectin |
| _T30 | 700-706 | FMAID:165145 | denotes | microM |
| _T31 | 954-964 | FMAID:62860 | denotes | neutrophil |
| _T32 | 954-964 | FMAID:167159 | denotes | neutrophil |
| _T33 | 954-964 | FMAID:167158 | denotes | neutrophil |
| _T34 | 976-987 | FMAID:242132 | denotes | interleukin |
| _T35 | 976-987 | FMAID:242133 | denotes | interleukin |
| _T36 | 976-987 | FMAID:264827 | denotes | interleukin |
| _T37 | 976-987 | FMAID:242138 | denotes | interleukin |
| _T38 | 976-987 | FMAID:264828 | denotes | interleukin |
| _T39 | 976-987 | FMAID:242139 | denotes | interleukin |
| _T40 | 976-987 | FMAID:264829 | denotes | interleukin |
| _T41 | 976-987 | FMAID:264826 | denotes | interleukin |
| _T42 | 976-987 | FMAID:201491 | denotes | interleukin |
| _T43 | 976-987 | FMAID:86578 | denotes | interleukin |
| _T44 | 976-987 | FMAID:264830 | denotes | interleukin |
| _T45 | 976-987 | FMAID:242137 | denotes | interleukin |
| _T46 | 976-987 | FMAID:242134 | denotes | interleukin |
| _T47 | 976-987 | FMAID:264825 | denotes | interleukin |
| _T48 | 976-987 | FMAID:201492 | denotes | interleukin |
| _T49 | 976-987 | FMAID:86579 | denotes | interleukin |
| _T50 | 976-987 | FMAID:242140 | denotes | interleukin |
| _T51 | 976-987 | FMAID:264824 | denotes | interleukin |
| _T52 | 976-987 | FMAID:264823 | denotes | interleukin |
| _T53 | 976-987 | FMAID:264831 | denotes | interleukin |
| _T54 | 976-987 | FMAID:264822 | denotes | interleukin |
| _T55 | 976-987 | FMAID:242142 | denotes | interleukin |
| _T56 | 976-987 | FMAID:242143 | denotes | interleukin |
| _T57 | 976-987 | FMAID:264821 | denotes | interleukin |
| _T58 | 976-987 | FMAID:197973 | denotes | interleukin |
| _T59 | 976-987 | FMAID:84051 | denotes | interleukin |
| _T60 | 976-987 | FMAID:264832 | denotes | interleukin |
| _T61 | 976-987 | FMAID:242135 | denotes | interleukin |
| _T62 | 976-987 | FMAID:242136 | denotes | interleukin |
| _T63 | 976-987 | FMAID:242141 | denotes | interleukin |
| _T64 | 976-994 | FMAID:201496 | denotes | interleukin (IL)-1 |
| _T65 | 976-994 | FMAID:86583 | denotes | interleukin (IL)-1 |
| _T66 | 1016-1030 | FMAID:70317 | denotes | umbilical vein |
| _T67 | 1016-1030 | FMAID:171155 | denotes | umbilical vein |
| _T68 | 1026-1030 | FMAID:217490 | denotes | vein |
| _T69 | 1026-1030 | FMAID:217063 | denotes | vein |
| _T70 | 1026-1030 | FMAID:50723 | denotes | vein |
| _T71 | 1026-1030 | FMAID:185470 | denotes | vein |
| _T72 | 1026-1030 | FMAID:171667 | denotes | vein |
| _T73 | 1031-1042 | FMAID:63916 | denotes | endothelial |
| _T74 | 1031-1042 | FMAID:162384 | denotes | endothelial |
| _T75 | 1031-1048 | FMAID:69075 | denotes | endothelial cells |
| _T76 | 1031-1048 | FMAID:164926 | denotes | endothelial cells |
| _T77 | 1031-1048 | FMAID:66772 | denotes | endothelial cells |
| _T78 | 1031-1048 | FMAID:169653 | denotes | endothelial cells |
| _T79 | 1043-1048 | FMAID:169002 | denotes | cells |
| _T80 | 1043-1048 | FMAID:68646 | denotes | cells |
| _T81 | 1104-1115 | FMAID:167158 | denotes | neutrophils |
| _T82 | 1104-1115 | FMAID:62860 | denotes | neutrophils |
| _T83 | 1104-1115 | FMAID:167159 | denotes | neutrophils |
| _T84 | 1137-1143 | FMAID:165145 | denotes | microM |
| _T85 | 1198-1213 | FMAID:196731 | denotes | oligosaccharide |
| _T86 | 1198-1213 | FMAID:82742 | denotes | oligosaccharide |
| _T87 | 1335-1346 | FMAID:162384 | denotes | endothelial |
| _T88 | 1335-1346 | FMAID:63916 | denotes | endothelial |
| _T89 | 1335-1352 | FMAID:164926 | denotes | endothelial cells |
| _T90 | 1335-1352 | FMAID:66772 | denotes | endothelial cells |
| _T91 | 1335-1352 | FMAID:169653 | denotes | endothelial cells |
| _T92 | 1335-1352 | FMAID:69075 | denotes | endothelial cells |
| _T93 | 1347-1352 | FMAID:169002 | denotes | cells |
| _T94 | 1347-1352 | FMAID:68646 | denotes | cells |
| _T95 | 1364-1374 | FMAID:167267 | denotes | E-selectin |
| _T96 | 1364-1374 | FMAID:62932 | denotes | E-selectin |
| _T97 | 1364-1374 | FMAID:167265 | denotes | E-selectin |
| _T98 | 1364-1374 | FMAID:62933 | denotes | E-selectin |
| _T99 | 1364-1374 | FMAID:62931 | denotes | E-selectin |
| _T100 | 1364-1374 | FMAID:167268 | denotes | E-selectin |
| _T101 | 1366-1374 | FMAID:165243 | denotes | selectin |
| _T102 | 1366-1374 | FMAID:61795 | denotes | selectin |
| _T103 | 1443-1461 | FMAID:196735 | denotes | lipopolysaccharide |
| _T104 | 1443-1461 | FMAID:196779 | denotes | lipopolysaccharide |
| _T105 | 1443-1461 | FMAID:82785 | denotes | lipopolysaccharide |
| _T106 | 1443-1461 | FMAID:82746 | denotes | lipopolysaccharide |
| _T107 | 1517-1522 | FMAID:68646 | denotes | cells |
| _T108 | 1517-1522 | FMAID:169002 | denotes | cells |
| _T109 | 1533-1543 | FMAID:167267 | denotes | E-selectin |
| _T110 | 1533-1543 | FMAID:62932 | denotes | E-selectin |
| _T111 | 1533-1543 | FMAID:62931 | denotes | E-selectin |
| _T112 | 1533-1543 | FMAID:167265 | denotes | E-selectin |
| _T113 | 1533-1543 | FMAID:167268 | denotes | E-selectin |
| _T114 | 1533-1543 | FMAID:62933 | denotes | E-selectin |
| _T115 | 1535-1543 | FMAID:61795 | denotes | selectin |
| _T116 | 1535-1543 | FMAID:165243 | denotes | selectin |
| _T117 | 1596-1606 | FMAID:62931 | denotes | E-selectin |
| _T118 | 1596-1606 | FMAID:62932 | denotes | E-selectin |
| _T119 | 1596-1606 | FMAID:167267 | denotes | E-selectin |
| _T120 | 1596-1606 | FMAID:167268 | denotes | E-selectin |
| _T121 | 1596-1606 | FMAID:62933 | denotes | E-selectin |
| _T122 | 1596-1606 | FMAID:167265 | denotes | E-selectin |
| _T123 | 1598-1606 | FMAID:61795 | denotes | selectin |
| _T124 | 1598-1606 | FMAID:165243 | denotes | selectin |
| _T125 | 1708-1718 | FMAID:167265 | denotes | E-selectin |
| _T126 | 1708-1718 | FMAID:167267 | denotes | E-selectin |
| _T127 | 1708-1718 | FMAID:62933 | denotes | E-selectin |
| _T128 | 1708-1718 | FMAID:167268 | denotes | E-selectin |
| _T129 | 1708-1718 | FMAID:62932 | denotes | E-selectin |
| _T130 | 1708-1718 | FMAID:62931 | denotes | E-selectin |
| _T131 | 1710-1718 | FMAID:165243 | denotes | selectin |
| _T132 | 1710-1718 | FMAID:61795 | denotes | selectin |
| _T133 | 1719-1727 | FMAID:167180 | denotes | antibody |
uniprot-human
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 45-55 | http://www.uniprot.org/uniprot/P16581 | denotes | E-selectin |
| T2 | 423-433 | http://www.uniprot.org/uniprot/P16581 | denotes | E-selectin |
| T3 | 1364-1374 | http://www.uniprot.org/uniprot/P16581 | denotes | E-selectin |
| T4 | 1533-1543 | http://www.uniprot.org/uniprot/P16581 | denotes | E-selectin |
| T5 | 1596-1606 | http://www.uniprot.org/uniprot/P16581 | denotes | E-selectin |
| T6 | 1708-1718 | http://www.uniprot.org/uniprot/P16581 | denotes | E-selectin |
| T7 | 174-180 | http://www.uniprot.org/uniprot/Q92988 | denotes | beta 1 |
| T8 | 232-238 | http://www.uniprot.org/uniprot/Q92988 | denotes | beta 1 |
| T9 | 993-999 | http://www.uniprot.org/uniprot/Q92988 | denotes | 1 beta |
| T10 | 396-398 | http://www.uniprot.org/uniprot/P11150 | denotes | HL |
| T11 | 396-398 | http://www.uniprot.org/uniprot/P35914 | denotes | HL |
| T12 | 396-398 | http://www.uniprot.org/uniprot/Q14469 | denotes | HL |
| T13 | 989-999 | http://www.uniprot.org/uniprot/P01584 | denotes | IL)-1 beta |
| T14 | 989-999 | http://www.uniprot.org/uniprot/P42701 | denotes | IL)-1 beta |
uniprot-mouse
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 45-55 | http://www.uniprot.org/uniprot/Q00690 | denotes | E-selectin |
| T2 | 423-433 | http://www.uniprot.org/uniprot/Q00690 | denotes | E-selectin |
| T3 | 1364-1374 | http://www.uniprot.org/uniprot/Q00690 | denotes | E-selectin |
| T4 | 1533-1543 | http://www.uniprot.org/uniprot/Q00690 | denotes | E-selectin |
| T5 | 1596-1606 | http://www.uniprot.org/uniprot/Q00690 | denotes | E-selectin |
| T6 | 1708-1718 | http://www.uniprot.org/uniprot/Q00690 | denotes | E-selectin |
| T7 | 396-398 | http://www.uniprot.org/uniprot/P27656 | denotes | HL |
| T8 | 396-398 | http://www.uniprot.org/uniprot/P38060 | denotes | HL |
| T9 | 989-999 | http://www.uniprot.org/uniprot/P10749 | denotes | IL)-1 beta |
| T10 | 1748-1750 | http://www.uniprot.org/uniprot/Q8VHK8 | denotes | AT |
GlycoBiology-NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 123-128 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
| T2 | 174-178 | http://purl.bioontology.org/ontology/NCBITAXON/3554 | denotes | beta |
| T3 | 174-178 | http://purl.bioontology.org/ontology/NCBITAXON/158455 | denotes | beta |
| T4 | 232-236 | http://purl.bioontology.org/ontology/NCBITAXON/3554 | denotes | beta |
| T5 | 232-236 | http://purl.bioontology.org/ontology/NCBITAXON/158455 | denotes | beta |
| T6 | 402-407 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
| T7 | 619-633 | http://purl.bioontology.org/ontology/NCBITAXON/1206048 | denotes | SLeX inhibited |
| T8 | 995-999 | http://purl.bioontology.org/ontology/NCBITAXON/158455 | denotes | beta |
| T9 | 995-999 | http://purl.bioontology.org/ontology/NCBITAXON/3554 | denotes | beta |
| T10 | 1043-1048 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
| T11 | 1347-1352 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
| T12 | 1490-1492 | http://purl.bioontology.org/ontology/NCBITAXON/13893 | denotes | co |
| T13 | 1517-1522 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 12-18 | http://purl.obolibrary.org/obo/GO_0097503 | denotes | sialyl |
| T2 | 56-78 | http://purl.obolibrary.org/obo/GO_0033627 | denotes | mediated cell adhesion |
| T3 | 65-78 | http://purl.obolibrary.org/obo/GO_0007155 | denotes | cell adhesion |
| T4 | 101-128 | http://purl.obolibrary.org/obo/GO_0042118 | denotes | activated endothelial cells |
| T5 | 101-128 | http://purl.obolibrary.org/obo/GO_0045603 | denotes | activated endothelial cells |
| T6 | 101-128 | http://purl.obolibrary.org/obo/GO_1901552 | denotes | activated endothelial cells |
| T7 | 101-128 | http://purl.obolibrary.org/obo/GO_0001938 | denotes | activated endothelial cells |
| T8 | 270-280 | http://purl.obolibrary.org/obo/GO_0000746 | denotes | conjugated |
| T9 | 449-459 | http://purl.obolibrary.org/obo/GO_0000746 | denotes | conjugated |
| T10 | 853-862 | http://purl.obolibrary.org/obo/GO_0000746 | denotes | conjugate |
| T11 | 377-392 | http://purl.obolibrary.org/obo/GO_0051100 | denotes | inhibit binding |
| T12 | 544-559 | http://purl.obolibrary.org/obo/GO_0051100 | denotes | inhibit binding |
| T13 | 989-999 | http://purl.obolibrary.org/obo/GO_0032611 | denotes | IL)-1 beta |
| T14 | 993-1009 | http://purl.obolibrary.org/obo/GO_0036364 | denotes | 1 beta-activated |
| T15 | 993-1009 | http://purl.obolibrary.org/obo/GO_0046509 | denotes | 1 beta-activated |
| T16 | 1507-1522 | http://purl.obolibrary.org/obo/GO_0001775 | denotes | activated cells |
GO-MF
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 47-55 | http://purl.obolibrary.org/obo/GO_0030246 | denotes | selectin |
| T2 | 425-433 | http://purl.obolibrary.org/obo/GO_0030246 | denotes | selectin |
| T3 | 1366-1374 | http://purl.obolibrary.org/obo/GO_0030246 | denotes | selectin |
| T4 | 1535-1543 | http://purl.obolibrary.org/obo/GO_0030246 | denotes | selectin |
| T5 | 1598-1606 | http://purl.obolibrary.org/obo/GO_0030246 | denotes | selectin |
| T6 | 1710-1718 | http://purl.obolibrary.org/obo/GO_0030246 | denotes | selectin |
| T7 | 385-392 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
| T8 | 484-491 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
| T9 | 552-559 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
| T10 | 639-646 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
| T11 | 1625-1632 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
| T12 | 1692-1699 | http://purl.obolibrary.org/obo/GO_0070026 | denotes | binding |
| T13 | 385-392 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
| T14 | 484-491 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
| T15 | 552-559 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
| T16 | 639-646 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
| T17 | 1625-1632 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
| T18 | 1692-1699 | http://purl.obolibrary.org/obo/GO_0003680 | denotes | binding |
| T19 | 385-392 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
| T20 | 484-491 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
| T21 | 552-559 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
| T22 | 639-646 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
| T23 | 1625-1632 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
| T24 | 1692-1699 | http://purl.obolibrary.org/obo/GO_0017091 | denotes | binding |
| T25 | 385-392 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
| T26 | 484-491 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
| T27 | 552-559 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
| T28 | 639-646 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
| T29 | 1625-1632 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
| T30 | 1692-1699 | http://purl.obolibrary.org/obo/GO_0005488 | denotes | binding |
| T31 | 989-994 | http://purl.obolibrary.org/obo/GO_0005149 | denotes | IL)-1 |
| T32 | 1719-1727 | http://purl.obolibrary.org/obo/GO_0003823 | denotes | antibody |
GO-CC
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 65-69 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T2 | 479-483 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T3 | 123-128 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
| T4 | 402-407 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
| T5 | 1043-1048 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
| T6 | 1347-1352 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
| T7 | 1517-1522 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
UBERON-AE
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 1016-1030 | http://purl.obolibrary.org/obo/UBERON_0002066 | denotes | umbilical vein |
| T2 | 1016-1042 | http://purl.obolibrary.org/obo/UBERON_0007777 | denotes | umbilical vein endothelial |
| T3 | 1026-1030 | http://purl.obolibrary.org/obo/UBERON_0001638 | denotes | vein |
NGLY1-deficiency
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-NGLY1-deficiency-B_T1 | 198-204 | chem:24139 | denotes | GlcNAc |
GlycoBiology-MAT
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 1026-1030 | http://purl.obolibrary.org/obo/MAT_0000037 | denotes | vein |
GlyTouCan-IUPAC
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| GlycanIUPAC_T1 | 154-160 | "http://rdf.glycoinfo.org/glycan/G76685HR" | denotes | Neu5Ac |
| GlycanIUPAC_T2 | 212-218 | "http://rdf.glycoinfo.org/glycan/G76685HR" | denotes | Neu5Ac |
| GlycanIUPAC_T3 | 154-160 | "http://rdf.glycoinfo.org/glycan/G65881BF" | denotes | Neu5Ac |
| GlycanIUPAC_T4 | 212-218 | "http://rdf.glycoinfo.org/glycan/G65881BF" | denotes | Neu5Ac |
| GlycanIUPAC_T5 | 154-160 | "http://rdf.glycoinfo.org/glycan/G82702MH" | denotes | Neu5Ac |
| GlycanIUPAC_T6 | 212-218 | "http://rdf.glycoinfo.org/glycan/G82702MH" | denotes | Neu5Ac |
| GlycanIUPAC_T7 | 154-160 | "http://rdf.glycoinfo.org/glycan/G51494MY" | denotes | Neu5Ac |
| GlycanIUPAC_T8 | 212-218 | "http://rdf.glycoinfo.org/glycan/G51494MY" | denotes | Neu5Ac |
| GlycanIUPAC_T9 | 154-160 | "http://rdf.glycoinfo.org/glycan/G37109XL" | denotes | Neu5Ac |
| GlycanIUPAC_T10 | 212-218 | "http://rdf.glycoinfo.org/glycan/G37109XL" | denotes | Neu5Ac |
| GlycanIUPAC_T11 | 154-160 | "http://rdf.glycoinfo.org/glycan/G47427MX" | denotes | Neu5Ac |
| GlycanIUPAC_T12 | 212-218 | "http://rdf.glycoinfo.org/glycan/G47427MX" | denotes | Neu5Ac |
| GlycanIUPAC_T13 | 154-160 | "http://rdf.glycoinfo.org/glycan/G89927NS" | denotes | Neu5Ac |
| GlycanIUPAC_T14 | 212-218 | "http://rdf.glycoinfo.org/glycan/G89927NS" | denotes | Neu5Ac |
| GlycanIUPAC_T15 | 183-186 | "http://rdf.glycoinfo.org/glycan/G49112ZN" | denotes | Fuc |
| GlycanIUPAC_T16 | 183-186 | "http://rdf.glycoinfo.org/glycan/G50059AJ" | denotes | Fuc |
| GlycanIUPAC_T17 | 183-186 | "http://rdf.glycoinfo.org/glycan/G76218YK" | denotes | Fuc |
| GlycanIUPAC_T18 | 183-186 | "http://rdf.glycoinfo.org/glycan/G50102KR" | denotes | Fuc |
| GlycanIUPAC_T19 | 183-186 | "http://rdf.glycoinfo.org/glycan/G10717VS" | denotes | Fuc |
| GlycanIUPAC_T20 | 183-186 | "http://rdf.glycoinfo.org/glycan/G60524RK" | denotes | Fuc |
| GlycanIUPAC_T21 | 183-186 | "http://rdf.glycoinfo.org/glycan/G84407TT" | denotes | Fuc |
| GlycanIUPAC_T22 | 183-186 | "http://rdf.glycoinfo.org/glycan/G64717JT" | denotes | Fuc |
| GlycanIUPAC_T23 | 183-186 | "http://rdf.glycoinfo.org/glycan/G45003TT" | denotes | Fuc |
| GlycanIUPAC_T24 | 183-186 | "http://rdf.glycoinfo.org/glycan/G73923FP" | denotes | Fuc |
| GlycanIUPAC_T25 | 183-186 | "http://rdf.glycoinfo.org/glycan/G78231MB" | denotes | Fuc |
| GlycanIUPAC_T26 | 183-186 | "http://rdf.glycoinfo.org/glycan/G80487UG" | denotes | Fuc |
| GlycanIUPAC_T27 | 183-186 | "http://rdf.glycoinfo.org/glycan/G29758MI" | denotes | Fuc |
| GlycanIUPAC_T28 | 183-186 | "http://rdf.glycoinfo.org/glycan/G02671KD" | denotes | Fuc |
| GlycanIUPAC_T29 | 183-186 | "http://rdf.glycoinfo.org/glycan/G57926TZ" | denotes | Fuc |
| GlycanIUPAC_T30 | 183-186 | "http://rdf.glycoinfo.org/glycan/G41718FD" | denotes | Fuc |
| GlycanIUPAC_T31 | 183-186 | "http://rdf.glycoinfo.org/glycan/G99840FL" | denotes | Fuc |
| GlycanIUPAC_T32 | 183-186 | "http://rdf.glycoinfo.org/glycan/G64321UX" | denotes | Fuc |
| GlycanIUPAC_T33 | 183-186 | "http://rdf.glycoinfo.org/glycan/G11231EG" | denotes | Fuc |
| GlycanIUPAC_T34 | 183-186 | "http://rdf.glycoinfo.org/glycan/G62741TN" | denotes | Fuc |
| GlycanIUPAC_T35 | 183-186 | "http://rdf.glycoinfo.org/glycan/G51576ZQ" | denotes | Fuc |
| GlycanIUPAC_T36 | 183-186 | "http://rdf.glycoinfo.org/glycan/G66056LD" | denotes | Fuc |
| GlycanIUPAC_T37 | 183-186 | "http://rdf.glycoinfo.org/glycan/G02768BF" | denotes | Fuc |
| GlycanIUPAC_T38 | 183-186 | "http://rdf.glycoinfo.org/glycan/G26168RO" | denotes | Fuc |
| GlycanIUPAC_T39 | 183-186 | "http://rdf.glycoinfo.org/glycan/G42890HL" | denotes | Fuc |
| GlycanIUPAC_T40 | 183-186 | "http://rdf.glycoinfo.org/glycan/G17533VU" | denotes | Fuc |
| GlycanIUPAC_T41 | 183-186 | "http://rdf.glycoinfo.org/glycan/G34306RG" | denotes | Fuc |
| GlycanIUPAC_T42 | 183-186 | "http://rdf.glycoinfo.org/glycan/G88735KU" | denotes | Fuc |
| GlycanIUPAC_T43 | 183-186 | "http://rdf.glycoinfo.org/glycan/G82605UA" | denotes | Fuc |
| GlycanIUPAC_T44 | 198-204 | "http://rdf.glycoinfo.org/glycan/G26693XF" | denotes | GlcNAc |
| GlycanIUPAC_T45 | 198-204 | "http://rdf.glycoinfo.org/glycan/G01864SU" | denotes | GlcNAc |
| GlycanIUPAC_T46 | 198-204 | "http://rdf.glycoinfo.org/glycan/G17605FD" | denotes | GlcNAc |
| GlycanIUPAC_T47 | 198-204 | "http://rdf.glycoinfo.org/glycan/G41950LU" | denotes | GlcNAc |
| GlycanIUPAC_T48 | 198-204 | "http://rdf.glycoinfo.org/glycan/G57195RJ" | denotes | GlcNAc |
| GlycanIUPAC_T49 | 198-204 | "http://rdf.glycoinfo.org/glycan/G85391SA" | denotes | GlcNAc |
| GlycanIUPAC_T50 | 198-204 | "http://rdf.glycoinfo.org/glycan/G89565QL" | denotes | GlcNAc |
| GlycanIUPAC_T51 | 198-204 | "http://rdf.glycoinfo.org/glycan/G80869MR" | denotes | GlcNAc |
| GlycanIUPAC_T52 | 198-204 | "http://rdf.glycoinfo.org/glycan/G55978NL" | denotes | GlcNAc |
| GlycanIUPAC_T53 | 198-204 | "http://rdf.glycoinfo.org/glycan/G54644LT" | denotes | GlcNAc |
| GlycanIUPAC_T54 | 198-204 | "http://rdf.glycoinfo.org/glycan/G25694UG" | denotes | GlcNAc |
| GlycanIUPAC_T55 | 198-204 | "http://rdf.glycoinfo.org/glycan/G25126RB" | denotes | GlcNAc |
| GlycanIUPAC_T56 | 198-204 | "http://rdf.glycoinfo.org/glycan/G51848AD" | denotes | GlcNAc |
| GlycanIUPAC_T57 | 198-204 | "http://rdf.glycoinfo.org/glycan/G94667GM" | denotes | GlcNAc |
| GlycanIUPAC_T58 | 198-204 | "http://rdf.glycoinfo.org/glycan/G30124BO" | denotes | GlcNAc |
| GlycanIUPAC_T59 | 198-204 | "http://rdf.glycoinfo.org/glycan/G82777EZ" | denotes | GlcNAc |
| GlycanIUPAC_T60 | 198-204 | "http://rdf.glycoinfo.org/glycan/G10151YZ" | denotes | GlcNAc |
| GlycanIUPAC_T61 | 198-204 | "http://rdf.glycoinfo.org/glycan/G17585ZM" | denotes | GlcNAc |
| GlycanIUPAC_T62 | 198-204 | "http://rdf.glycoinfo.org/glycan/G04411CJ" | denotes | GlcNAc |
| GlycanIUPAC_T63 | 198-204 | "http://rdf.glycoinfo.org/glycan/G38254HJ" | denotes | GlcNAc |
| GlycanIUPAC_T64 | 198-204 | "http://rdf.glycoinfo.org/glycan/G75188FS" | denotes | GlcNAc |
| GlycanIUPAC_T65 | 198-204 | "http://rdf.glycoinfo.org/glycan/G70374VG" | denotes | GlcNAc |
| GlycanIUPAC_T66 | 198-204 | "http://rdf.glycoinfo.org/glycan/G45176LJ" | denotes | GlcNAc |
| GlycanIUPAC_T67 | 198-204 | "http://rdf.glycoinfo.org/glycan/G30874VW" | denotes | GlcNAc |
| GlycanIUPAC_T68 | 198-204 | "http://rdf.glycoinfo.org/glycan/G69333MI" | denotes | GlcNAc |
| GlycanIUPAC_T69 | 198-204 | "http://rdf.glycoinfo.org/glycan/G10676XO" | denotes | GlcNAc |
| GlycanIUPAC_T70 | 198-204 | "http://rdf.glycoinfo.org/glycan/G14843DJ" | denotes | GlcNAc |
| GlycanIUPAC_T71 | 198-204 | "http://rdf.glycoinfo.org/glycan/G47546FR" | denotes | GlcNAc |
| GlycanIUPAC_T72 | 198-204 | "http://rdf.glycoinfo.org/glycan/G73695ZM" | denotes | GlcNAc |
| GlycanIUPAC_T73 | 198-204 | "http://rdf.glycoinfo.org/glycan/G31923TJ" | denotes | GlcNAc |
| GlycanIUPAC_T74 | 198-204 | "http://rdf.glycoinfo.org/glycan/G60519EP" | denotes | GlcNAc |
| GlycanIUPAC_T75 | 198-204 | "http://rdf.glycoinfo.org/glycan/G07933IA" | denotes | GlcNAc |
| GlycanIUPAC_T76 | 198-204 | "http://rdf.glycoinfo.org/glycan/G40745NH" | denotes | GlcNAc |
| GlycanIUPAC_T77 | 198-204 | "http://rdf.glycoinfo.org/glycan/G54496YV" | denotes | GlcNAc |
| GlycanIUPAC_T78 | 198-204 | "http://rdf.glycoinfo.org/glycan/G62953SQ" | denotes | GlcNAc |
| GlycanIUPAC_T79 | 198-204 | "http://rdf.glycoinfo.org/glycan/G70070AY" | denotes | GlcNAc |
| GlycanIUPAC_T80 | 198-204 | "http://rdf.glycoinfo.org/glycan/G78792WC" | denotes | GlcNAc |
| GlycanIUPAC_T81 | 198-204 | "http://rdf.glycoinfo.org/glycan/G25238AV" | denotes | GlcNAc |
| GlycanIUPAC_T82 | 198-204 | "http://rdf.glycoinfo.org/glycan/G40510DP" | denotes | GlcNAc |
| GlycanIUPAC_T83 | 198-204 | "http://rdf.glycoinfo.org/glycan/G61120TK" | denotes | GlcNAc |
| GlycanIUPAC_T84 | 198-204 | "http://rdf.glycoinfo.org/glycan/G41342KV" | denotes | GlcNAc |
| GlycanIUPAC_T85 | 198-204 | "http://rdf.glycoinfo.org/glycan/G90703NA" | denotes | GlcNAc |
| GlycanIUPAC_T86 | 198-204 | "http://rdf.glycoinfo.org/glycan/G01591HR" | denotes | GlcNAc |
| GlycanIUPAC_T87 | 198-204 | "http://rdf.glycoinfo.org/glycan/G56520XN" | denotes | GlcNAc |
| GlycanIUPAC_T88 | 198-204 | "http://rdf.glycoinfo.org/glycan/G81830JX" | denotes | GlcNAc |
GlycoBiology-Motifs
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 19-22 | http://rdf.glycoinfo.org/glycan/G00051MO | denotes | LeX |
| T2 | 148-152 | http://rdf.glycoinfo.org/glycan/G00054MO | denotes | SLeX |
| T3 | 319-323 | http://rdf.glycoinfo.org/glycan/G00054MO | denotes | SLeX |
| T4 | 440-444 | http://rdf.glycoinfo.org/glycan/G00054MO | denotes | SLeX |
| T5 | 460-464 | http://rdf.glycoinfo.org/glycan/G00054MO | denotes | SLeX |
| T6 | 619-623 | http://rdf.glycoinfo.org/glycan/G00054MO | denotes | SLeX |
| T7 | 836-840 | http://rdf.glycoinfo.org/glycan/G00054MO | denotes | SLeX |
| T8 | 916-920 | http://rdf.glycoinfo.org/glycan/G00054MO | denotes | SLeX |
| T9 | 1193-1197 | http://rdf.glycoinfo.org/glycan/G00054MO | denotes | SLeX |
| T10 | 1276-1280 | http://rdf.glycoinfo.org/glycan/G00054MO | denotes | SLeX |
| T11 | 1389-1393 | http://rdf.glycoinfo.org/glycan/G00054MO | denotes | SLeX |
| T12 | 1636-1640 | http://rdf.glycoinfo.org/glycan/G00054MO | denotes | SLeX |
| T13 | 1463-1466 | http://rdf.glycoinfo.org/glycan/G00022MO | denotes | LPS |
Lectin
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| Lectin_T1 | 47-55 | https://acgg.asia/db/lfdb/LfDB0013 | denotes | selectin |
| Lectin_T2 | 425-433 | https://acgg.asia/db/lfdb/LfDB0013 | denotes | selectin |
| Lectin_T3 | 1366-1374 | https://acgg.asia/db/lfdb/LfDB0013 | denotes | selectin |
| Lectin_T4 | 1535-1543 | https://acgg.asia/db/lfdb/LfDB0013 | denotes | selectin |
| Lectin_T5 | 1598-1606 | https://acgg.asia/db/lfdb/LfDB0013 | denotes | selectin |
| Lectin_T6 | 1710-1718 | https://acgg.asia/db/lfdb/LfDB0013 | denotes | selectin |
| Lectin_T7 | 45-55 | https://acgg.asia/db/lfdb/LfDB0043 | denotes | E-selectin |
| Lectin_T8 | 423-433 | https://acgg.asia/db/lfdb/LfDB0043 | denotes | E-selectin |
| Lectin_T9 | 1364-1374 | https://acgg.asia/db/lfdb/LfDB0043 | denotes | E-selectin |
| Lectin_T10 | 1533-1543 | https://acgg.asia/db/lfdb/LfDB0043 | denotes | E-selectin |
| Lectin_T11 | 1596-1606 | https://acgg.asia/db/lfdb/LfDB0043 | denotes | E-selectin |
| Lectin_T12 | 1708-1718 | https://acgg.asia/db/lfdb/LfDB0043 | denotes | E-selectin |
| Lectin_T13 | 47-55 | https://acgg.asia/db/lfdb/LfDB0142 | denotes | selectin |
| Lectin_T14 | 425-433 | https://acgg.asia/db/lfdb/LfDB0142 | denotes | selectin |
| Lectin_T15 | 1366-1374 | https://acgg.asia/db/lfdb/LfDB0142 | denotes | selectin |
| Lectin_T16 | 1535-1543 | https://acgg.asia/db/lfdb/LfDB0142 | denotes | selectin |
| Lectin_T17 | 1598-1606 | https://acgg.asia/db/lfdb/LfDB0142 | denotes | selectin |
| Lectin_T18 | 1710-1718 | https://acgg.asia/db/lfdb/LfDB0142 | denotes | selectin |
performance-test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 1026-1030 | http://purl.obolibrary.org/obo/UBERON_0001638 | denotes | vein |
| PD-UBERON-AE-B_T2 | 1016-1030 | http://purl.obolibrary.org/obo/UBERON_0002066 | denotes | umbilical vein |
| PD-UBERON-AE-B_T3 | 1016-1042 | http://purl.obolibrary.org/obo/UBERON_0007777 | denotes | umbilical vein endothelial |
Anatomy-MAT
| Id | Subject | Object | Predicate | Lexical cue | mat_id |
|---|---|---|---|---|---|
| T1 | 1026-1030 | Body_part | denotes | vein | http://purl.obolibrary.org/obo/MAT_0000037 |
Glycan-GlyCosmos
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 154-160 | Glycan | denotes | Neu5Ac | https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR |
| T2 | 212-218 | Glycan | denotes | Neu5Ac | https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR |
GlyCosmos15-NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 1010-1015 | OrganismTaxon | denotes | human | 9606 |
GlyCosmos15-CL
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 111-128 | Cell | denotes | endothelial cells | http://purl.obolibrary.org/obo/CL:0000115 |
| T2 | 954-964 | Cell | denotes | neutrophil | http://purl.obolibrary.org/obo/CL:0000775 |
| T3 | 1026-1048 | Cell | denotes | vein endothelial cells | http://purl.obolibrary.org/obo/CL:0002543 |
| T4 | 1104-1115 | Cell | denotes | neutrophils | http://purl.obolibrary.org/obo/CL:0000775 |
| T5 | 1335-1352 | Cell | denotes | endothelial cells | http://purl.obolibrary.org/obo/CL:0000115 |
GlyCosmos15-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 111-128 | Body_part | denotes | endothelial cells | http://purl.obolibrary.org/obo/CL_0000115 |
| T2 | 954-964 | Body_part | denotes | neutrophil | http://purl.obolibrary.org/obo/CL_0000775 |
| T3 | 1016-1030 | Body_part | denotes | umbilical vein | http://purl.obolibrary.org/obo/UBERON_0002066 |
| T4 | 1031-1048 | Body_part | denotes | endothelial cells | http://purl.obolibrary.org/obo/CL_0000115 |
| T5 | 1104-1115 | Body_part | denotes | neutrophils | http://purl.obolibrary.org/obo/CL_0000775 |
| T6 | 1335-1352 | Body_part | denotes | endothelial cells | http://purl.obolibrary.org/obo/CL_0000115 |
GlyCosmos15-MAT
| Id | Subject | Object | Predicate | Lexical cue | mat_id |
|---|---|---|---|---|---|
| T1 | 1026-1030 | Body_part | denotes | vein | http://purl.obolibrary.org/obo/MAT_0000037 |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-129 | Sentence | denotes | Multivalent sialyl-LeX: potent inhibitors of E-selectin-mediated cell adhesion; reagent for staining activated endothelial cells. |
| TextSentencer_T2 | 130-434 | Sentence | denotes | Free, monovalent, SLeX (Neu5Ac alpha 2-3Gal beta 1-4(Fuc alpha 1-3)-GlcNAc), SLn (Neu5Ac alpha 2-3Gal beta 1-4GlcNAc) and corresponding BSA-conjugated forms--displaying different ratios of SLeX and SLn to protein--were tested for their ability to inhibit binding of HL-60 cells to immobilized E-selectin. |
| TextSentencer_T3 | 435-519 | Sentence | denotes | Free SLeX and conjugated SLeX-BSA inhibited cell binding in a dose-dependent manner. |
| TextSentencer_T4 | 520-560 | Sentence | denotes | SLn and SLn-BSA did not inhibit binding. |
| TextSentencer_T5 | 561-841 | Sentence | denotes | SLeX16BSA (16 mol tetrasaccharide/mol BSA) and monovalent SLeX inhibited cell binding with measured inhibitory concentrations (IC50S) of 1 microM and 1 mM, respectively, demonstrating a three-order-of-magnitude enhancement of inhibitory activity with the multivalent form of SLeX. |
| TextSentencer_T6 | 842-929 | Sentence | denotes | A SLex7BSA conjugate was 10-fold less potent than those with 11 or 16 mol SLeX/mol BSA. |
| TextSentencer_T7 | 930-1275 | Sentence | denotes | An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM. |
| TextSentencer_T8 | 1276-1375 | Sentence | denotes | SLeX-BSA was found to be an excellent reagent for staining endothelial cells expressing E-selectin. |
| TextSentencer_T9 | 1376-1575 | Sentence | denotes | Biotinylated SLeX-BSA in conjunction with Texas red avidin-stained lipopolysaccharide (LPS)-activated HUVECs, and co-incubation of activated cells with anti-E-selectin, specifically blocked staining. |
| TextSentencer_T10 | 1576-1761 | Sentence | denotes | The distribution of E-selectin, as determined by binding of SLeX-BSA, was virtually identical with that obtained by binding of anti-E-selectin antibody.(ABSTRACT TRUNCATED AT 250 WORDS) |
| T1 | 0-129 | Sentence | denotes | Multivalent sialyl-LeX: potent inhibitors of E-selectin-mediated cell adhesion; reagent for staining activated endothelial cells. |
| T2 | 130-434 | Sentence | denotes | Free, monovalent, SLeX (Neu5Ac alpha 2-3Gal beta 1-4(Fuc alpha 1-3)-GlcNAc), SLn (Neu5Ac alpha 2-3Gal beta 1-4GlcNAc) and corresponding BSA-conjugated forms--displaying different ratios of SLeX and SLn to protein--were tested for their ability to inhibit binding of HL-60 cells to immobilized E-selectin. |
| T3 | 435-519 | Sentence | denotes | Free SLeX and conjugated SLeX-BSA inhibited cell binding in a dose-dependent manner. |
| T4 | 520-560 | Sentence | denotes | SLn and SLn-BSA did not inhibit binding. |
| T5 | 561-841 | Sentence | denotes | SLeX16BSA (16 mol tetrasaccharide/mol BSA) and monovalent SLeX inhibited cell binding with measured inhibitory concentrations (IC50S) of 1 microM and 1 mM, respectively, demonstrating a three-order-of-magnitude enhancement of inhibitory activity with the multivalent form of SLeX. |
| T6 | 842-929 | Sentence | denotes | A SLex7BSA conjugate was 10-fold less potent than those with 11 or 16 mol SLeX/mol BSA. |
| T7 | 930-1275 | Sentence | denotes | An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM. |
| T8 | 1276-1375 | Sentence | denotes | SLeX-BSA was found to be an excellent reagent for staining endothelial cells expressing E-selectin. |
| T9 | 1376-1575 | Sentence | denotes | Biotinylated SLeX-BSA in conjunction with Texas red avidin-stained lipopolysaccharide (LPS)-activated HUVECs, and co-incubation of activated cells with anti-E-selectin, specifically blocked staining. |
| T10 | 1576-1761 | Sentence | denotes | The distribution of E-selectin, as determined by binding of SLeX-BSA, was virtually identical with that obtained by binding of anti-E-selectin antibody.(ABSTRACT TRUNCATED AT 250 WORDS) |
| T1 | 0-129 | Sentence | denotes | Multivalent sialyl-LeX: potent inhibitors of E-selectin-mediated cell adhesion; reagent for staining activated endothelial cells. |
| T2 | 130-434 | Sentence | denotes | Free, monovalent, SLeX (Neu5Ac alpha 2-3Gal beta 1-4(Fuc alpha 1-3)-GlcNAc), SLn (Neu5Ac alpha 2-3Gal beta 1-4GlcNAc) and corresponding BSA-conjugated forms--displaying different ratios of SLeX and SLn to protein--were tested for their ability to inhibit binding of HL-60 cells to immobilized E-selectin. |
| T3 | 435-519 | Sentence | denotes | Free SLeX and conjugated SLeX-BSA inhibited cell binding in a dose-dependent manner. |
| T4 | 520-560 | Sentence | denotes | SLn and SLn-BSA did not inhibit binding. |
| T5 | 561-841 | Sentence | denotes | SLeX16BSA (16 mol tetrasaccharide/mol BSA) and monovalent SLeX inhibited cell binding with measured inhibitory concentrations (IC50S) of 1 microM and 1 mM, respectively, demonstrating a three-order-of-magnitude enhancement of inhibitory activity with the multivalent form of SLeX. |
| T6 | 842-929 | Sentence | denotes | A SLex7BSA conjugate was 10-fold less potent than those with 11 or 16 mol SLeX/mol BSA. |
| T7 | 930-1275 | Sentence | denotes | An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM. |
| T8 | 1276-1375 | Sentence | denotes | SLeX-BSA was found to be an excellent reagent for staining endothelial cells expressing E-selectin. |
| T9 | 1376-1575 | Sentence | denotes | Biotinylated SLeX-BSA in conjunction with Texas red avidin-stained lipopolysaccharide (LPS)-activated HUVECs, and co-incubation of activated cells with anti-E-selectin, specifically blocked staining. |
| T10 | 1576-1761 | Sentence | denotes | The distribution of E-selectin, as determined by binding of SLeX-BSA, was virtually identical with that obtained by binding of anti-E-selectin antibody.(ABSTRACT TRUNCATED AT 250 WORDS) |
GlyCosmos15-Sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-129 | Sentence | denotes | Multivalent sialyl-LeX: potent inhibitors of E-selectin-mediated cell adhesion; reagent for staining activated endothelial cells. |
| T2 | 130-434 | Sentence | denotes | Free, monovalent, SLeX (Neu5Ac alpha 2-3Gal beta 1-4(Fuc alpha 1-3)-GlcNAc), SLn (Neu5Ac alpha 2-3Gal beta 1-4GlcNAc) and corresponding BSA-conjugated forms--displaying different ratios of SLeX and SLn to protein--were tested for their ability to inhibit binding of HL-60 cells to immobilized E-selectin. |
| T3 | 435-519 | Sentence | denotes | Free SLeX and conjugated SLeX-BSA inhibited cell binding in a dose-dependent manner. |
| T4 | 520-560 | Sentence | denotes | SLn and SLn-BSA did not inhibit binding. |
| T5 | 561-841 | Sentence | denotes | SLeX16BSA (16 mol tetrasaccharide/mol BSA) and monovalent SLeX inhibited cell binding with measured inhibitory concentrations (IC50S) of 1 microM and 1 mM, respectively, demonstrating a three-order-of-magnitude enhancement of inhibitory activity with the multivalent form of SLeX. |
| T6 | 842-929 | Sentence | denotes | A SLex7BSA conjugate was 10-fold less potent than those with 11 or 16 mol SLeX/mol BSA. |
| T7 | 930-1275 | Sentence | denotes | An assay which measured neutrophil rolling on interleukin (IL)-1 beta-activated human umbilical vein endothelial cells (HUVECs) showed 50% reduction in the number of rolling neutrophils in the presence of 1 microM SLeX16BSA, whereas the level of free, monovalent SLeX oligosaccharide required to produce the same effect was approximately 0.3 mM. |
| T8 | 1276-1375 | Sentence | denotes | SLeX-BSA was found to be an excellent reagent for staining endothelial cells expressing E-selectin. |
| T9 | 1376-1575 | Sentence | denotes | Biotinylated SLeX-BSA in conjunction with Texas red avidin-stained lipopolysaccharide (LPS)-activated HUVECs, and co-incubation of activated cells with anti-E-selectin, specifically blocked staining. |
| T10 | 1576-1761 | Sentence | denotes | The distribution of E-selectin, as determined by binding of SLeX-BSA, was virtually identical with that obtained by binding of anti-E-selectin antibody.(ABSTRACT TRUNCATED AT 250 WORDS) |
GlyCosmos15-Glycan
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 154-160 | Glycan | denotes | Neu5Ac | https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR |
| T2 | 212-218 | Glycan | denotes | Neu5Ac | https://api.glycosmos.org/wurcs2image/latest/png/binary/G76685HR |
NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 1010-1015 | OrganismTaxon | denotes | human | 9606 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 111-128 | Body_part | denotes | endothelial cells | http://purl.obolibrary.org/obo/CL_0000115 |
| T2 | 954-964 | Body_part | denotes | neutrophil | http://purl.obolibrary.org/obo/CL_0000775 |
| T3 | 1016-1030 | Body_part | denotes | umbilical vein | http://purl.obolibrary.org/obo/UBERON_0002066 |
| T4 | 1031-1048 | Body_part | denotes | endothelial cells | http://purl.obolibrary.org/obo/CL_0000115 |
| T5 | 1104-1115 | Body_part | denotes | neutrophils | http://purl.obolibrary.org/obo/CL_0000775 |
| T6 | 1335-1352 | Body_part | denotes | endothelial cells | http://purl.obolibrary.org/obo/CL_0000115 |
CL-cell
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 111-128 | Cell | denotes | endothelial cells | http://purl.obolibrary.org/obo/CL:0000115 |
| T2 | 954-964 | Cell | denotes | neutrophil | http://purl.obolibrary.org/obo/CL:0000775 |
| T3 | 1026-1048 | Cell | denotes | vein endothelial cells | http://purl.obolibrary.org/obo/CL:0002543 |
| T4 | 1104-1115 | Cell | denotes | neutrophils | http://purl.obolibrary.org/obo/CL:0000775 |
| T5 | 1335-1352 | Cell | denotes | endothelial cells | http://purl.obolibrary.org/obo/CL:0000115 |